Rivaroxaban cuts recurrent blood clots in obese patients
(HealthDay)—Real-world evidence shows that rivaroxaban reduces the risk for recurrent venous thromboembolism (VTE) in morbidly obese patients, with similar safety and efficacy as warfarin, according to a study published ...
Sep 30, 2019
0
2